Frank L. Hurley
Chief Tech/Sci/R&D Officer at Symphony Dynamo, Inc.
Profile
Frank L.
Hurley was the founder of RRD International LLC, which was founded in 2002, where he held the title of Chairman & Chief Scientific Officer.
Currently, he is the Chief Scientific Officer at Symphony Evolution, Inc. and Symphony Dynamo, Inc. Dr. Hurley's former positions include Chief Executive Officer at Symphony Allegro, Inc., Chairman & Chief Scientific Officer at BRI International, Inc., and Chief Scientific Officer at Symphony Neuro Development Co., Symphony Genisis, Inc., and Symphony Icon, Inc. Dr. Hurley holds a doctorate degree from The Johns Hopkins University and an undergraduate degree from Georgetown University.
Frank L. Hurley active positions
| Companies | Position | Start |
|---|---|---|
Symphony Dynamo, Inc.
 Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | - |
Symphony Evolution, Inc.
 Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Chief Tech/Sci/R&D Officer | - |
Former positions of Frank L. Hurley
| Companies | Position | End |
|---|---|---|
RRD International LLC
 RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Founder | - |
Symphony Neuro Development Co.
 Symphony Neuro Development Co. Pharmaceuticals: MajorHealth Technology Symphony Neuro Development Co. manufactures pharmaceuticals. It is engaged in the research, development, and commercialization of proprietary drugs that target the hospital and neurology markets. The company is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | - |
BRI International, Inc.
 BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Chairman | - |
Symphony Icon, Inc.
 Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Chief Tech/Sci/R&D Officer | - |
Symphony Genisis, Inc.
 Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Chief Tech/Sci/R&D Officer | - |
Training of Frank L. Hurley
| The Johns Hopkins University | Doctorate Degree |
| Georgetown University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
BRI International, Inc.
BRI International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., BRI International, Inc. is a pharmaceutical research and development company with 445 employees. The company is based in Arlington, VA. BRI International was acquired by Quintiles Transnational Corp. on November 22, 1996 for $130.63 million. The company was founded by Harold Solomon. | Commercial Services |
Symphony Neuro Development Co.
Symphony Neuro Development Co. Pharmaceuticals: MajorHealth Technology Symphony Neuro Development Co. manufactures pharmaceuticals. It is engaged in the research, development, and commercialization of proprietary drugs that target the hospital and neurology markets. The company is headquartered in Rockville, MD. | Health Technology |
Symphony Evolution, Inc.
Symphony Evolution, Inc. Pharmaceuticals: MajorHealth Technology Symphony Evolution, Inc. engages in the manufacture of biopharmaceutical drugs. It develops therapeutics to treat cancer and diabetic nephropathy. The company was founded on October 19, 2006 and is headquartered in Wilmington, DE. | Health Technology |
Symphony Genisis, Inc.
Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Health Technology |
Symphony Dynamo, Inc.
Symphony Dynamo, Inc. Pharmaceuticals: MajorHealth Technology Symphony Dynamo, Inc. manufactures biopharmaceutical drugs. It was created to advance TLR-9 based therapeutics in hepatitis B therapy and hepatitis C therapy and cancer. The company was founded in 2002 and is headquartered in Rockville, MD. | Health Technology |
Symphony Allegro, Inc.
 Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Health Technology |
RRD International LLC
RRD International LLC Miscellaneous Commercial ServicesCommercial Services RRD International LLC develops biopharmaceutical products. The firm offers product development support to biotechnology, pharmaceutical and medical device companies. Its services include development, strategic planning, program management and research. The company was founded by Frank L. Hurley and Charles W. Finn in 2002 and is headquartered in Rockville, MD. | Commercial Services |
- Stock Market
- Insiders
- Frank L. Hurley
